Columbia Presbyterian Medical Center
New York, 10032, United States
NCT Number: NCT00279669
Premature infants stand a risk of danger to the layer of the eye that creates sight that, if untreated, can cause severe vision problems, leading to blindness in some cases. This research study will use ultrasound to examine the eye for retinal changes of prematurity.
Looking for future studies?
Notify MeAll sexes
Observational
New York, 10032, United States
Retinopathy of prematurity requires the early detection of retinopathy in neonates with a gestational age of < 28 weeks and a birth weight <1500 g. These evaluations require pupillary dilation, diagnostic expertise, consume much time and expense and are not without morbidity.
B-scan ultrasonography using a hand-held probe is part of the current ophthalmologist's armamentarium, providing a non-invasive view of the eye and avoiding the morbidity associated with mydriatic drops used for pupillary dilation.
We will use a simple water bath enclosure for a standard 20 MHz probe currently in general ophthalmic use to determine whether this simple technique might supplant indirect ophthalmoscopy as a screening technique. We will compare, using masked observers, the clinical findings of indirect ophthalmoscopy of neonatal infants with ultrasonic findings to determine if a correlation in the stages of retinopathy of prematurity (ROP) between the two techniques existed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
premature birth
Exclusion criteria
contact ultrasound examination
Other names: Quantel Cinescan
Weill Medical College of Cornell University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05387941
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Lund, Skåne County, Sweden
View Trial DetailsNCT02820662
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Dijon, France
View Trial DetailsNCT06517836
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Portland, Oregon, United States
View Trial DetailsNCT05133999
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Paris, France
View Trial Details